Which drug gets ERCP patients home quicker? new study aims to find out

NCT ID NCT06136585

First seen Jan 04, 2026 · Last updated May 06, 2026 · Updated 16 times

Summary

This study compares two medicines, sugammadex and neostigmine, to see which one helps patients recover faster from muscle paralysis used during an ERCP procedure. About 80 adults having outpatient ERCP will be randomly assigned to receive one of the two drugs. The main goal is to see which drug shortens the time from reversal to being ready for discharge, and also to check for side effects like nausea.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROMUSCULAR BLOCKS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cleveland Clinic Fairview Hospital

    RECRUITING

    Cleveland, Ohio, 44111, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.